Associazione Nazionale Medici Cardiologi Ospedalieri

www.anmco.it

CONGRESS ABSTRACT

CONGRESS ABSTRACT

Categorie
Real world usage of ranolazine for antiarrhythmic purposes: single center experience
Anno:
2024
Introduction: Ranolazine is a late sodium current blocking drug developed as an antianginal agent, with good preliminary efficacy data even for antiarrhythmic purposes (both at atrial and at ventricular level). Objectives: To evaluate patients’ clinical characteristics and antiarrhythmic efficacy of ranolazine in subjects with a history of atrial and/or…
Leggi di più
Vai of Marshall ethanol infusione: sometimes, less can be more. A case report of safety without deceasing efficacy.
Anno:
2024
Vein of Marshall ethanol infusion (VoM-EI) is a new therapeutic option effective for decreasing the likelihood of atrial tachyarrhythmias in patients with persistent atrial fibrillation (PAF). Complications related to retrograde EI described in the literature are rare but can have grave consequences for the patient. Our clinical case shows…
Leggi di più
PERcutaneouS coronary intErventions in patients treated with Oral anticoagulant therapy: baseline clinical Characteristics of the PERSEO Registry
Anno:
2024
BACKGROUND International guidelines recommend a dual antithrombotic therapy (DAT) with direct oral anticoagulant (DOAC) for patients on chronic oral anticoagulant therapy (OAT) undergoing percutaneous coronary intervention with stent implantation (PCI-S). However, the implementation of practice Guidelines in the “real world” is often a complex exercise. Aim of the multicenter…
Leggi di più
CLINICAL AND GENETIC FEATURES OF JUVENILE ONSET LONE ATRIAL FIBRILLATION
Anno:
2024
Background: Juvenile-onset lone atrial fibrillation (LAF) may be the initial manifestation of an othrewise concealed channelopathy or cardiomyopathy (CMP). Clinical characteristics, genetic background and proper management are still largely unknown. Purpose: describe the clinical and genetic characteristics of patients with juvenile-onset LAF. Methods: We enrolled patients referred to our…
Leggi di più
A network meta-analysis comparing pulsed-field ablation (PFA) and other current ablation therapies for paroxysmal atrial fibrillation.
Anno:
2024
Introduction. Pulsed-field ablation (PFA) has emerged as a non-thermal catheter-based treatment for paroxysmal atrial fibrillation. This study aimed to compare the efficacy of PFA with various conventional thermal ablation methods that are currently available. Method. Randomised controlled trials were retrieved to compare atrial tachyarrhythmia recurrence among any combination of…
Leggi di più
A COMPLEX CASE OF EARLY ONSET ATRIAL FIBRILLATION IN AN ENDURANCE ATHLETE: THE IMPORTANCE OF FAMILY HISTORY
Anno:
2024
Introduction: early onset atrial fibrillation (AF) in an endurance athlete represents a challenge for the cardiologist, especially in apparent absence of an overt structural heart disease. Different genetic variants have been associated with early onset AF but indications to genetic testing are still under definition. Case: a 54-year-old man…
Leggi di più
Feasibility and micro-costing analysis of a same-day discharge protocol for catheter ablation of atrial fibrillation: A pilot study using cryoballoon ablation.
Anno:
2024
Background: Catheter ablation (CA) is a well-established treatment for atrial fibrillation (AF). Due to the ageing population, increasing prevalence of AF risk factors, improving detection methods for AF, and broadening indications for ablation, CA for AF is the most common resource-consuming ablation procedure, strongly impacting waiting list times and…
Leggi di più
ATRIAL FIBRILLATION IN A CIED POPULATION: RESULTS FROM A TELEMONITORING FOLLOW-UP
Anno:
2024
Background: telemedicine has emerged as a crucial tool in managing patients with Cardiac Implantable Electronic Devices (CIED), addressing the common challenge of the Atrial Fibrillation (AF) in cardiology. The incidence of AF in CIED recipients varies widely (30-70%), influenced by implant indication, device type, and population characteristics. This study…
Leggi di più
NOVEL INTEGRATED IMAGING PARAMETERS FOR RISK STRATIFICATION OF ATRIAL FIBRILLATION IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY
Anno:
2024
Abstract Background Atrial fibrillation (AF) impacts prognosis of hypertrophic cardiomyopathy (HCM) by promoting progressive heart failure (HF) and increasing risk of stroke. Over the past years, several indexes and methods to predict AF among HCM patients have been proposed. However, they are limited by a lack of accuracy. Aims…
Leggi di più
FOLATES-RELATED AND BONE MARROW DISORDERS PROMOTE ATRIAL CARDIOMYOPATHY INPATIENTS AFFECTED BY PAROXYSMAL ATRIAL FIBRILLATION VIA BOTH EPCS AND ENDOTHELIAL DYSFUNCTION
Anno:
2024
Background: Atrial Cardiomyopathy (AC) has been recently postulated to explain those embolic strokes not due to atrial fibrillation (AF) and paradoxical embolism. Pathogenic mechanisms underlying AC are still largely unknown. Folate cycle disorders (FD) are a yet underrated pro-thrombotic dysmetabolism. FD could hinder both endothelial and circulating endothelial progenitor…
Leggi di più

A.N.M.C.O. – Via La Marmora 36, 50121 Firenze (Italy) – Partita I.V.A. 05469530488 – Codice Fiscale 01301130488 – Privacy
www.anmco.it | segreteria@anmco.it

Cookie Policy Privacy Policy

Seguici su

Facebook Twitter Youtube Linkedin Instagram Telegram